ArticleDermatology and therapy2026

Patient-Level Cumulative Clinical Benefit of Brodalumab Over 52 Weeks: A Multicentre Real-World Study-IL PSO (Italian Landscape Psoriasis).

Luca Potestio et al.PubMed ↗Publisher ↗

No numbers read from the abstract.